gms | German Medical Science

86. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

13.05. - 16.05.2015, Berlin

Incidence of streptococcal carriers and evaluation of different ways of treatment

Meeting Abstract

Suche in Medline nach

  • corresponding author Sonil Mone - Spitali Rajonal Vlore, Vlore, Albania
  • Pjerin Radovani - University Hospital Center "Mother Teresa", Tirane, Albania
  • Genc Burazeri - Health Public Institute, Tirane, Albania
  • Albana Zani - Development Institute Center, Vlore, Albania

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 86. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Berlin, 13.-16.05.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15hnod039

doi: 10.3205/15hnod039, urn:nbn:de:0183-15hnod0395

Veröffentlicht: 26. März 2015

© 2015 Mone et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen. Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden. Lizenz-Angaben siehe http://creativecommons.org/licenses/by-nc-nd/3.0/.


Gliederung

Text

Introduction: GABHS tonsillopharyngitis is the only form of pharingitis, where antibiotic therapy is definitely indicated, reducing at minimum dangerous complications.

Objective: To evaluate the role of group A βhemolytic streptococcus in acute or chronic tonsillopharyngitis, and to identify the best treatment regimen.

Methods: Several clinic groups of children are chosen for the study,1.Children who are presented to the clinic for routine examinations, with no apparent illness,2.Children with upper respiratory infections symptoms, who have not received any treatment.3.Children treated for GABHS infections with an oral cefuroxime for 10 days,4.Children treated for GABHS infections with 3 days of injectable cefuroxime , continued with 7 days of oral Cefuroxime,5.Children who underwent surgery for Tonsillectomy with or without Adenoidectomy, for chronic GABHS infections, with no symptoms of pharyngitis at the time of examination.The study was conducted for about 2 years, with children consulted in the general policlinic, and in the ENT hospital department. Patients were chosen from 5 to 15 years old.Throat culture in sheep blood agar was chosen as still the best way for identifying GABHS.

Results: GABHS was prevalent in 11% (10/94) children of group I, in 25% (22/86) children of group II, in 47% (33/70) children of group III, in 39% (27/70) children of group IV and 4% (5/120) children of group V. There was a statistically significant difference in the prevalence of GABHS between study groups (Fisher’s exact test: P<0.001).

Conclusions: The prevalence of GABHS was the highest among children with upper respiratory infections symptoms, who did not receive any treatment. Conversely, children who underwent tonsillectomy displayed the lowest prevalence of GABHS.

Der Erstautor gibt keinen Interessenkonflikt an.